Neal E Dunlap, M.D.


Doctor of Medicine, University of Cincinnati College of Medicine, 2006
Internship Internal Medicine, University Hospital Cincinnati, OH, 2006 – 2007
Residency Radiation Oncology, University of Virginia, 2007 – 2010
Chief Resident Radiation Oncology, University of Virginia 2010 - 2011
Board Certified, American Board of Radiology in Radiation Oncology 2012
Fellowship, Proton Radiation, Paul Sherrer Institute, Villigen, Switzerland 2010

Curriculum Vitae

Current Positions:

Assistant Professor of Medicine, Department of Radiation Oncology
Associate Clinical Director of the Multidisciplinary Head and Neck Cancer Program, James Graham Brown Cancer Center

Clinical Focus:

My clinical focus is primarily on multidisciplinary approaches to the treatment of lung cancer, esophageal cancer, head & neck cancers and liver cancers.  I work within multidisciplinary clinics in collaboration with medical oncologist, surgeons, pulmonologists, speech pathologists, and psychologists.  All of our new patients are presented in a multidisciplinary fashion in a tumor board forum to ensure our patients have appropriate, personalized treatment.

Additionally, I focus on the adoption of new radiation technologies for the treatment of both primary tumors and recurrences.  These technologies represent the most advanced treatment tools available, including the Cyberknife Radiosurgical System, the Varian TrueBeam with RapidArc, helical Tomotherapy, and Calypso.

Research Focus:

My research interest include the application of new treatment technologies in treatment of lung, liver and head & neck malignancies in order to improve outcomes and reduce side effects.  I currently have investigator initiated trials open for the re-treatment of lung cancers after previous radiation, evaluation of early radiation-induced lung injury with 4-dimensional CT and the treatment of inoperable pancreatic cancer using radiosurgery.  I am currently the institutional principal investigator for multiple national cooperative group studies through NRG/RTOG in the treatment of lung and head & neck cancers.

Literature Cited:

  1. Bhatt A, Goodwin N, Cash E, Bhatt G, Silverman C, Spanos W, Bumpous J, Potts K, Redman R, Allison W, Dunlap NE:  Impact of Transcutaneous Neuromuscular Electrical Stimulation on dysphagia in head and neck cancer patients treated with definitive chemoradiation.  Accepted to Head & Neck January 2014
  2. Mezera M, Chandrasekhar M, Kloecker G, Van Berkel V, Bousamra M, Dunlap NE:  Stereotactic body radiation therapy as salvage for intrathoracic recurrence after definitive stereotactic body radiation therapy for early-stage lung cancer.  Journal of Solid Tumors 2014:4(2):4-13.
  3. Parks J, Kloecker G, Woo S, Dunlap NE:  Stereotactic body radiation therapy for intrathoracic recurrence in patients with previously irradiated locally advanced non-small cell lung cancer.  Accepted American Journal of Clinical Oncology December 18, 2013
  4. Shaughnessy JN, Farghaly H, Wilson L, Redman R, Potts K, Bumpous J, Silverman C, Dunlap NE.: HPV: A factor in organ preservation for locally advanced larynx & hypopharynx cancer?  Am J Otolaryngol.  Accepted August 2013. Epub ahead of print
  5. Lee K, Kloecker G, Pan J, Rai S, Dunlap NE:  The Integration of Multimodality Care for the Treatment of Small Cell Lung Cancer in a Rural Population and its Impact on Survival.  Am J Clin Oncol 2013 Sept 21.  Epub ahead of print

PubMed Information